EndoZip™ Begins Pivotal Trial to Advance Automated ESG in U.S.
CAESAREA, Israel, Dec. 10, 2025 — Nitinotes Ltd., an early commercial-stage medical technology company developing fully automated endoluminal suturing...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAESAREA, Israel, Dec. 10, 2025 — Nitinotes Ltd., an early commercial-stage medical technology company developing fully automated endoluminal suturing...
Eindhoven, Netherlands — Nov. 24, 2025 — ONWARD Medical N.V. announced a series of major scientific, regulatory, and commercial...
DULUTH, Ga., Oct. 7, 2025 — Bridge to Life Ltd. has received FDA 510(k) clearance for its multi-sourced Belzer...
MONT-SAINT-GUIBERT, Belgium, Oct. 6, 2025 — Nyxoah SA announced that the first U.S. commercial patients have been implanted with...
BASEL, Switzerland, Oct. 6, 2025 — Roche announced that it has received CE-mark approval for the AI-based Kidney Klinrisk...
